Hong-zhi Wang, MD, MS

Cancer Hospital, Chinese Academy of Medical Science, Peking Union Medical College

BeiJing, Beijing

Disclosures:

Presentations

Sep 30

309 - Efficacy and Safety of Camrelizumab and Apatinib in Combination with IMRT in Unresectable Hepatocellular Carcinoma: A Non-Randomised Phase 2 Study

01:15pm - 01:25pm PT